...
首页> 外文期刊>European Journal of Pharmacology: An International Journal >Effects of ajmaline on rate-dependent atrioventricular node properties. Potential role in experimental atrioventricular re-entrant tachycardia.
【24h】

Effects of ajmaline on rate-dependent atrioventricular node properties. Potential role in experimental atrioventricular re-entrant tachycardia.

机译:阿玛琳对速率依赖性房室结性质的影响。在实验性房室折返性心动过速中的潜在作用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Ajmaline is a well-known atrioventricular (AV) node depressant agent, but its effects on functional properties of the AV node and on experimental AV re-entrant tachycardia have not been explored. The aims of the present study were (1) to determine whether ajmaline administration modifies the rate-dependent properties of the AV node and (2) to correlate these changes with the actions of ajmaline on an in vitro model of AV re-entrant tachycardia. Selective stimulation protocols and mathematical formulations were used to quantify independently AV node recovery, facilitation, and fatigue in 10 isolated rabbit AV nodes. Ajmaline decreased facilitation and fatigue and had no significant effect on AV node recovery. The most important effect of ajmaline was rate-induced prolongation of AV node effective refractory period, resulting in a greater increase in tachycardia cycle length. AV re-entrant tachycardia was sustained when AV effective refractory period divided to tachycardia cycle length was less than 1, ajmaline suppressed AV re-entrant tachycardia by increasing the slope of the AV effective refractory period divided to tachycardia cycle length versus tachycardia rate relation, causing the critical ratio of 1 to be attained at a slower rate. A mathematical model incorporating quantitative descriptors of recovery, facilitation, and fatigue accounted for changes in nodal conduction time, AV effective refractory period, tachycardia cycle length, and AV effective refractory period divided to tachycardia cycle length under all conditions. It can be concluded that (1) ajmaline increases AV conduction time, decreases AV node fatigue, and facilitation, without altering AV node recovery. (2) Ajmaline significantly prolongs AV effective refractory period in a rate-dependent manner. (3) These changes play a role in ajmaline's actions on experimental AV re-entrant tachycardia. Ajmaline's ability to terminate re-entrant supraventricular tachycardia may be due, at least in part, to its ability to amplify the rate-induced prolongation of the nodal refractory period.
机译:Ajmaline是一种众所周知的房室结(AV)降压药,但尚未探讨其对AV结的功能特性和实验性AV折返性心动过速的影响。本研究的目的是(1)确定是否以amamaline给药改变了房室结的速率依赖性,以及(2)将这些变化与amamaline在房室折返性心动过速体外模型上的作用相关联。选择性刺激方案和数学公式被用来独立地量化10个孤立的兔房室结的房室结的恢复,促进和疲劳。 Ajmaline减少了促进和疲劳,对房室结的恢复没有显着影响。艾玛琳最重要的作用是速率诱导的房室结有效不应期的延长,导致心动过速周期的增加更大。当AV有效不应期除以心动过速周期长度小于1时,AV折返性心动过速持续存在,通过增加AV有效不应期除以心动过速周期长度与心动过速率关系的斜率,阿马啉抑制了AV折返性心动过速以较低的速率获得1的临界比率。数学模型结合了恢复,促进和疲劳的定量描述,解释了在所有情况下节点传导时间,AV有效不应期,心动过速周期长度和AV有效不应期除以心动过速周期长度的变化。可以得出的结论是:(1)碧玺增加了AV传导时间,减少了AV节点的疲劳和便利,而没有改变AV节点的恢复。 (2)依玛琳以速率依赖性方式显着延长AV有效不应期。 (3)这些变化在阿玛琳对实验性AV折返性心动过速的作用中起作用。 Ajmaline终止折返性室上性心动过速的能力可能至少部分是由于其放大速率诱导的结节不应期延长的能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号